Fig. 4From: Impact of China’s zero mark-up drug policy on drug cost of NCDs’ outpatients: an interrupted time series analysisEstimated changes in average drug costs for patients of different sexes with diabetes (a), hypertension (b), and coronary heart disease (c). On the left is male and on the right is femaleBack to article page